Details of the patient cohort including their age, ER status, progesterone receptor status, HER-2 receptor status, histology, tumour grade, pre-chemotherapy tumour size, and chemotherapy or target therapy regimen are described in Table 1. This evidence concerns the gene PGR and neoplasm.